VBLT   $0.18  -9.99% Market Closed

Vascular Biogenics Ltd
Last Events:

2023-03-29 Trend pattern changed from расходящийся треугольник to восходящий клин.

2023-03-29 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: signal line crossed the middle level.

2023-03-29 Signal in MACD changed from bullish to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

2023-03-29 Signal in RSI changed from bullish recovery to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-03-29 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-02-10 the price crossed down the moving average line and formed a short-term downside trend.

2023-03-29 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-02-09 the price crossed down the moving average line and formed a short-term downside trend.

2023-03-29 Trend Power changed from strong to medium strength.

2023-03-29 Trend changed from flat and down to down and flat.


Current temperature: 1.86
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.10
Target: 5.00
High with 48% probability: 0.80
Analyst Recommendations:
Number of estimates 1
Target Price Mean 5.00
Mean unverified/preliminary 5.00 / 5.00
Target Price Low / High 5.00 / 5.00
Median / STD DEV 5.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell Sell -
stoch Sell Sell -
ma20 Sell - -
ma50 Sell - -
ma100 Sell - -
Candlestick PatternFeb. 17, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN IL0011327454
ceo Prof. Dror Harats M.D.
Website https://www.vblrx.com
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.